CN100409874C - 治疗肠胃疾病的天然芳香植物油中药胶囊及其生产方法 - Google Patents
治疗肠胃疾病的天然芳香植物油中药胶囊及其生产方法 Download PDFInfo
- Publication number
- CN100409874C CN100409874C CNB2005101073212A CN200510107321A CN100409874C CN 100409874 C CN100409874 C CN 100409874C CN B2005101073212 A CNB2005101073212 A CN B2005101073212A CN 200510107321 A CN200510107321 A CN 200510107321A CN 100409874 C CN100409874 C CN 100409874C
- Authority
- CN
- China
- Prior art keywords
- oil
- herba
- capsule
- chinese medicinal
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 32
- 125000003118 aryl group Chemical group 0.000 title claims abstract description 19
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 18
- 239000008158 vegetable oil Substances 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 208000018522 Gastrointestinal disease Diseases 0.000 title abstract 4
- 239000003921 oil Substances 0.000 claims abstract description 59
- 235000019198 oils Nutrition 0.000 claims abstract description 59
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims abstract description 21
- 235000019477 peppermint oil Nutrition 0.000 claims abstract description 21
- 239000010678 thyme oil Substances 0.000 claims abstract description 21
- 239000010619 basil oil Substances 0.000 claims abstract description 20
- 229940018006 basil oil Drugs 0.000 claims abstract description 20
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 19
- 239000008101 lactose Substances 0.000 claims abstract description 19
- 239000003814 drug Substances 0.000 claims description 33
- 241000717677 Mosla chinensis Species 0.000 claims description 21
- 208000010643 digestive system disease Diseases 0.000 claims description 19
- 208000018685 gastrointestinal system disease Diseases 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 2
- 208000001848 dysentery Diseases 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 3
- 230000003796 beauty Effects 0.000 abstract description 2
- 230000037303 wrinkles Effects 0.000 abstract description 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 239000010630 cinnamon oil Substances 0.000 abstract 2
- 235000012907 honey Nutrition 0.000 abstract 2
- 239000010661 oregano oil Substances 0.000 abstract 2
- 229940111617 oregano oil Drugs 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000003205 fragrance Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- 238000012360 testing method Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- 208000004429 Bacillary Dysentery Diseases 0.000 description 5
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 230000000242 pagocytic effect Effects 0.000 description 5
- 201000005113 shigellosis Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000003228 hemolysin Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000005577 Gastroenteritis Diseases 0.000 description 3
- 206010018910 Haemolysis Diseases 0.000 description 3
- 108010006464 Hemolysin Proteins Proteins 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 241001479543 Mentha x piperita Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000001771 mentha piperita Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- -1 Oleum Cinnamomi Substances 0.000 description 1
- 108700022034 Opsonin Proteins Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005316 response function Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101073212A CN100409874C (zh) | 2005-12-26 | 2005-12-26 | 治疗肠胃疾病的天然芳香植物油中药胶囊及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101073212A CN100409874C (zh) | 2005-12-26 | 2005-12-26 | 治疗肠胃疾病的天然芳香植物油中药胶囊及其生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1824072A CN1824072A (zh) | 2006-08-30 |
CN100409874C true CN100409874C (zh) | 2008-08-13 |
Family
ID=36935012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101073212A Expired - Fee Related CN100409874C (zh) | 2005-12-26 | 2005-12-26 | 治疗肠胃疾病的天然芳香植物油中药胶囊及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100409874C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103750033B (zh) * | 2014-01-03 | 2015-09-02 | 宁波大学 | 一种具有肠道保护功效的对虾饲料添加剂及其制备方法和应用 |
-
2005
- 2005-12-26 CN CNB2005101073212A patent/CN100409874C/zh not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
肠胃炎:冬季健康的隐形"杀手". 许梅.健康大视野,第12期. 2004 |
肠胃炎:冬季健康的隐形"杀手". 许梅.健康大视野,第12期. 2004 * |
芳香治疗法的药理效用. 八卷英彦,谢桂栋.香料香精化妆品,第4期. 1984 |
芳香治疗法的药理效用. 八卷英彦,谢桂栋.香料香精化妆品,第4期. 1984 * |
Also Published As
Publication number | Publication date |
---|---|
CN1824072A (zh) | 2006-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100553665C (zh) | 一种治疗咽喉炎的中药药物 | |
CN100444863C (zh) | 一种消炎解毒的中药组合物及其制备方法和用途 | |
CN100574784C (zh) | 一种内服治疗细菌性痢疾的中药组合物 | |
CN104352920A (zh) | 一种消食和胃的中药组合物 | |
CN102872359A (zh) | 一种治疗慢性胆囊炎的中药组合物 | |
CN100409874C (zh) | 治疗肠胃疾病的天然芳香植物油中药胶囊及其生产方法 | |
CN104162037A (zh) | 治疗脑出血的中药 | |
CN101023988B (zh) | 治疗小儿腹泻的中药制剂 | |
CN102872362A (zh) | 一种治疗慢性胆囊炎的中药 | |
CN103479884B (zh) | 一种治疗肝肾阴虚型胆囊炎的中药组合物 | |
CN112426448A (zh) | 一种养生茶的配制方法 | |
CN102669341B (zh) | 一种清热解毒的食品清热解毒茶冲剂 | |
CN103893488A (zh) | 一种治疗偏头痛的中药制剂及制备方法 | |
CN1088378C (zh) | 治疗慢性浅表性胃炎的中药口服液及其制备方法 | |
CN102266537B (zh) | 治疗慢性胃炎及胃十二指肠溃疡的中成药及其制备方法 | |
CN102228661B (zh) | 一种治疗慢性胆囊炎的中药合剂 | |
CN105250650A (zh) | 一种治疗功能性呕吐的中药制剂 | |
CN105616515A (zh) | 一种用于流行性脑脊髓膜炎的注射液 | |
CN104689202A (zh) | 治疗蛔虫病的中药 | |
CN104857407A (zh) | 一种具有降糖作用的中药 | |
CN104825919B (zh) | 一种治疗艾滋病发热的中药液 | |
CN101623360A (zh) | 一种治疗丹毒的中药组合物 | |
CN104367733A (zh) | 一种用于拔牙手术的中药麻醉剂及制备方法 | |
CN111265612A (zh) | 防治流感时疫的中药合剂 | |
CN102961722B (zh) | 一种治疗老年性便秘的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Xiangcheng Heng Cheung Co., Ltd. Assignor: Shi Kexing Contract fulfillment period: 2009.5.13 to 2014.5.13 contract change Contract record no.: 2009410000161 Denomination of invention: Natural aromatic vegetable oil Chinese medicine capsule for treating intestine and stomach disease and its production method Granted publication date: 20080813 License type: Exclusive license Record date: 2009.5.27 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.5.13 TO 2014.5.13; CHANGE OF CONTRACT Name of requester: XIANGCHENG CITY HENGXIANG CO.,LTD. Effective date: 20090527 |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |